These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 3937059

  • 1. The functional consequences of inhibition of monoamine oxidase type B: comparison of the pharmacological properties of L-deprenyl and MDL 72145.
    Fozard JR, Zreika M, Robin M, Palfreyman MG.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):186-93. PubMed ID: 3937059
    [Abstract] [Full Text] [Related]

  • 2. Selective inhibition of monoamine oxidase type B by MDL 72145 increases the central effects of L-dopa without modifying its cardiovascular effects.
    Fozard JR, Palfreyman MG, Robin M, Zreika M.
    Br J Pharmacol; 1986 Jan; 87(1):257-64. PubMed ID: 3082400
    [Abstract] [Full Text] [Related]

  • 3. Design and early clinical evaluation of selective inhibitors of monoamine oxidase.
    Palfreyman MG, McDonald IA, Bey P, Schechter PJ, Sjoerdsma A.
    Prog Neuropsychopharmacol Biol Psychiatry; 1988 Jan; 12(6):967-87. PubMed ID: 3266532
    [Abstract] [Full Text] [Related]

  • 4. Rat striatal monoamine oxidase-B inhibition by l-deprenyl and rasagiline: its relationship to 2-phenylethylamine-induced stereotypy and Parkinson's disease.
    Youdim MB, Tipton KF.
    Parkinsonism Relat Disord; 2002 Mar; 8(4):247-53. PubMed ID: 12039419
    [Abstract] [Full Text] [Related]

  • 5. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl.
    Karoum F.
    Br J Pharmacol; 1987 Feb; 90(2):335-45. PubMed ID: 3103805
    [Abstract] [Full Text] [Related]

  • 6. Prevention of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic toxicity in mice by MDL 72145, a selective inhibitor of MAO-B.
    Kindt MV, Heikkila RE.
    Life Sci; 1986 Apr 21; 38(16):1459-62. PubMed ID: 3084895
    [Abstract] [Full Text] [Related]

  • 7. Modification of blood pressure and nictitating membrane response to sympathetic amines by selective monoamine oxidase inhibitors, types A and B, in the cat.
    Finberg JP, Youdim MB.
    Br J Pharmacol; 1985 Jun 21; 85(2):541-6. PubMed ID: 3928010
    [Abstract] [Full Text] [Related]

  • 8. Enhancement of rat brain cytosolic monoamine oxidase activity by clorgyline. Comparison with (-)-deprenyl and MDL 72145.
    Azam M, Jain S, Baquer NZ.
    Biochem Pharmacol; 1990 Nov 15; 40(10):2215-8. PubMed ID: 2123104
    [Abstract] [Full Text] [Related]

  • 9. MDL 72145, an enzyme-activated irreversible inhibitor with selectivity for monoamine oxidase type B.
    Zreika M, McDonald IA, Bey P, Palfreyman MG.
    J Neurochem; 1984 Aug 15; 43(2):448-54. PubMed ID: 6736960
    [Abstract] [Full Text] [Related]

  • 10. Gonadal influences on the inhibition of monoamine oxidase type B activity.
    Vaccari A, Biassoni R.
    J Neurosci Res; 1982 Aug 15; 8(1):13-9. PubMed ID: 6816948
    [Abstract] [Full Text] [Related]

  • 11. Monoamine receptor sensitivity changes following chronic administration of MDL 72394, a site-directed inhibitor of monoamine oxidase.
    Palfreyman MG, Mir AK, Kubina M, Middlemiss DN, Richards M, Tricklebank MD, Fozard JR.
    Eur J Pharmacol; 1986 Oct 14; 130(1-2):73-89. PubMed ID: 3780861
    [Abstract] [Full Text] [Related]

  • 12. Stereoselectivity and isoenzyme selectivity of monoamine oxidase inhibitors. Enantiomers of amphetamine, N-methylamphetamine and deprenyl.
    Robinson JB.
    Biochem Pharmacol; 1985 Dec 01; 34(23):4105-8. PubMed ID: 3933519
    [Abstract] [Full Text] [Related]

  • 13. Tyramine-induced noradrenaline release from rat brain slices: prevention by (-)-deprenyl.
    Glover V, Pycock CJ, Sandler M.
    Br J Pharmacol; 1983 Sep 01; 80(1):141-8. PubMed ID: 6418254
    [Abstract] [Full Text] [Related]

  • 14. Metabolic transformation plays a primary role in the psychostimulant-like discriminative-stimulus effects of selegiline [(R)-(-)-deprenyl].
    Yasar S, Justinova Z, Lee SH, Stefanski R, Goldberg SR, Tanda G.
    J Pharmacol Exp Ther; 2006 Apr 01; 317(1):387-94. PubMed ID: 16352699
    [Abstract] [Full Text] [Related]

  • 15. Protection against DSP-4-induced neurotoxicity by deprenyl is not related to its inhibition of MAO B.
    Finnegan KT, Skratt JJ, Irwin I, DeLanney LE, Langston JW.
    Eur J Pharmacol; 1990 Aug 02; 184(1):119-26. PubMed ID: 2120076
    [Abstract] [Full Text] [Related]

  • 16. [Mechanism of inhibition by chlorgyline and deprenyl of tyramine deamination by mitochondrial monoamine oxidase of rat liver].
    Deverina IS.
    Biokhimiia; 1980 Oct 02; 45(10):1897-908. PubMed ID: 6786369
    [Abstract] [Full Text] [Related]

  • 17. In-vivo effects of (E)-2-(3',4'-dimethoxyphenyl)-3-fluoroallylamine (MDL 72145) on amine oxidase activities in the rat. Selective inhibition of semicarbazide-sensitive amine oxidase in vascular and brown adipose tissues.
    Elliott J, Callingham BA, Barrand MA.
    J Pharm Pharmacol; 1989 Jan 02; 41(1):37-41. PubMed ID: 2565962
    [Abstract] [Full Text] [Related]

  • 18. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
    Baud P, Arbilla S, Cantrill RC, Scatton B, Langer SZ.
    J Pharmacol Exp Ther; 1985 Oct 02; 235(1):220-9. PubMed ID: 3930699
    [Abstract] [Full Text] [Related]

  • 19. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
    Severina IS.
    Biokhimiia; 1979 Feb 02; 44(2):195-207. PubMed ID: 435561
    [Abstract] [Full Text] [Related]

  • 20. [History of deprenyl--the first selective inhibitor of monoamine oxidase type B].
    Knoll J.
    Vopr Med Khim; 1997 Feb 02; 43(6):482-93. PubMed ID: 9503565
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.